Sam Altman funds Merge Labs: The Next Brain-AI Frontier

Jan 19, 2026

Brain image
Brain image
Brain image

OpenAI Backs Sam Altman's New Brain-Computer Startup

OpenAI just led a $252 million seed round in Merge Labs, a non-invasive BCI company co-founded by Sam Altman. Valued at $850 million, it's aiming to connect brains and AI without implants.


Inspired by Sci-Fi, Grounded in Reality

Think about stories like Neuralink in the news or even movies where minds link with machines. Merge Labs is taking a fresh approach without surgery, using ultrasound and engineered proteins to read and write neural signals. You've probably noticed how BCI tech is evolving fast, and this feels like the next natural step.


Wait, What Are Engineered Proteins?

Engineered proteins are custom-designed molecules. For Merge Labs' approach, these proteins help make brain cells sensitive to non-invasive signals, so the system can read or influence neural activity safely from outside the skull.


Why this actually matters to YOU

Imagine controlling devices with thoughts or restoring lost abilities like movement for those with injuries. This non-invasive tech could make AI feel more natural in daily life, from health apps to creative tools.

It's the kind of progress that could touch everyone, making interactions smoother and more intuitive down the line.


Wait, What Is a BCI (Brain-Computer Interface)?

A BCI is tech that lets your brain communicate directly with computers, reading thoughts or signals to control things. Merge Labs focuses on non-invasive methods, meaning no surgery, just external ways like ultrasound to interact with neurons. It's like giving AI a window into how we think without opening the door.


Who’s behind it?

Co-founded by Sam Altman with experts like Mikhail Shapiro, Alex Blania, and Summer Norman, they're building on research from places like Forest Neurotech.

OpenAI led the recent round, joined by Bain Capital, Gabe Newell, and others like Vinod Khosla. At $850 million valuation, it's one of the largest seed rounds for neurotech.


Our Take

Early focus might be on medical uses like treating brain injuries or mental health. But longer term, it could enable AI-driven interfaces for everyone, from enhanced learning to direct thought control. Here's why that's exciting: it expands what we can imagine doing with our minds and machines together.

Taking the biggest tech, science and engineering headlines, remove the jargon and hype, and explain them in plain English so you actually understand what matters.

© 2026 Resonance Holdings LLC DBA NewsExplained Media

Powered by Humans

Taking the biggest tech, science and engineering headlines, remove the jargon and hype, and explain them in plain English so you actually understand what matters.

© 2026 Resonance Holdings LLC DBA NewsExplained Media

Powered by Humans

Taking the biggest tech, science and engineering headlines, remove the jargon and hype, and explain them in plain English so you actually understand what matters.

© 2026 Resonance Holdings LLC DBA NewsExplained Media

Powered by Humans